PDT Partners’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-72,500
| Closed | -$241K | – | 778 |
|
|
2021
Q1 | $241K | Buy |
+72,500
| New | +$241K | 0.02% | 661 |
|
|
2019
Q2 | – | Sell |
-30,200
| Closed | -$108K | – | 409 |
|
|
2019
Q1 | $108K | Hold |
30,200
| – | – | 0.01% | 413 |
|
|
2018
Q4 | $116K | Buy |
30,200
+6,150
| +26% | +$23.6K | 0.01% | 436 |
|
|
2018
Q3 | $227K | Sell |
24,050
-42,915
| -64% | -$405K | 0.01% | 422 |
|
|
2018
Q2 | $489K | Sell |
66,965
-5,535
| -8% | -$40.4K | 0.02% | 401 |
|
|
2018
Q1 | $363K | Sell |
72,500
-10,500
| -13% | -$52.6K | 0.01% | 475 |
|
|
2017
Q4 | $419K | Buy |
+83,000
| New | +$419K | 0.01% | 451 |
|
|
2016
Q4 | – | Sell |
-22,800
| Closed | -$78K | – | 494 |
|
|
2016
Q3 | $78K | Sell |
22,800
-7,400
| -25% | -$25.3K | ﹤0.01% | 468 |
|
|
2016
Q2 | $105K | Buy |
+30,200
| New | +$105K | 0.01% | 427 |
|
|
2015
Q3 | – | Sell |
-20,794
| Closed | -$247K | – | 1227 |
|
|
2015
Q2 | $247K | Buy |
+20,794
| New | +$247K | 0.01% | 1187 |
|